Featured Research

from universities, journals, and other organizations

New hormone for lowering blood sugar

Date:
April 3, 2012
Source:
Cell Press
Summary:
New evidence points to a hormone that leaves muscles gobbling up sugar as if they can't get enough. That factor, which can be coaxed out of fat stem cells, could lead to a new treatment to lower blood sugar and improve metabolism, according to a new report.

New evidence points to a hormone that leaves muscles gobbling up sugar as if they can't get enough. That factor, which can be coaxed out of fat stem cells, could lead to a new treatment to lower blood sugar and improve metabolism, according to a report in the April issue of Cell Metabolism, a Cell Press publication.

This new fat-derived hormone would appear to be a useful alternative or add-on to insulin; it can do essentially the same job, sending glucose out of the bloodstream and into muscle.

"It's like you've opened the door and now the glucose can come in," said Jonathan Graff of the University of Texas Southwestern Medical Center.

Graff's team manipulated a key developmental pathway in the fat stem cells of mice to find that the animals showed remarkably low blood sugar levels. The animals' muscles were taking up glucose at two to four times the usual rate thanks to an abundance of glucose transporters at their surfaces. That discovery was all the more striking because the animals also lacked fat stores, a condition known as lipodystrophy that normally results in just the opposite: high blood sugar and diabetes.

The mice could respond normally to insulin, but insulin surprisingly had nothing to do with the muscles' unusual appetite for sugar. The source for the change wasn't anything inherently different in the muscle itself either; it was something about those manipulated fat stem cells.

Further experiments revealed that the mouse muscles continued to take up extra sugar when they were isolated in the lab and exposed to blood serum. "It showed these effects were likely secondary to blood-borne signals sent by the manipulated fat cell progenitors," Graff says.

That signal can be generated only by fat stem cells, not mature fat cells. When the researchers made the same developmental manipulation in adult fat cells, they saw no such effect on blood sugar or muscle.

The findings highlight a new fat to muscle hormonal cue that would seem to have real therapeutic promise.

"If we can purify this factor and give it to people, there is potential for its use to lower and help control blood sugar," Graff says. Alternatively, there might be a way to encourage fat stem cells in the body to produce more of the anti-diabetic factor themselves.

Zeve et al.: "Wnt signaling activation in adipose progenitors promotes insulin-independent muscle glucose uptake."


Story Source:

The above story is based on materials provided by Cell Press. Note: Materials may be edited for content and length.


Journal Reference:

  1. Zeve et al. Wnt signaling activation in adipose progenitors promotes insulin-independent muscle glucose uptake. Cell Metabolism, 2012 DOI: 10.1016/j.cmet.2012.03.010

Cite This Page:

Cell Press. "New hormone for lowering blood sugar." ScienceDaily. ScienceDaily, 3 April 2012. <www.sciencedaily.com/releases/2012/04/120403124352.htm>.
Cell Press. (2012, April 3). New hormone for lowering blood sugar. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2012/04/120403124352.htm
Cell Press. "New hormone for lowering blood sugar." ScienceDaily. www.sciencedaily.com/releases/2012/04/120403124352.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins